维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="MN Dickler"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A phase Ⅱ trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer显示文摘	Dickler MN Rugo HS Eberle CA	2008	Clin Cancer Res2008，14，：	1
2	Maximizing the potential of bevacizumab in cancer treatment显示文摘	Bergsland E Dickler MN	2004	Oncologist2004，9，1：	1
3	Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer显示文摘	Dickler MN Cobleigh MA Miller KD	2009	Breast Cancer Res Treat2009，115，1：	1
4	Immunogenicity of a fu-cosyl-GM1 -keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer显示文摘	Dickler MN Ragupathi G Liu NX	1999	Clin Cancer Res1999，5，10：	1
5	Maximizing the potential of Bevacizumab in cancer treatment显示文摘	Bergsland E Dickler MN	2004	Oncologist2004，9，1：	1
6	Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast canc- er显示文摘	Dickler MN Cobleigh MA Miller KD	2009	Breast Cancer Res Treat2009，115，1：	1
7	A phase II trial of erlotin- ib in combination with bevaeizumab in patients with metastatic breast cancer 显示文摘	Dickler MN Rugo HS Eberle CA	2008	Clin Cancer Res2008，14，23：	1
8	The role of CDK4/6 inhibition in breast cancer 显示文摘	Murphy CG Dickler MN	2015	Oncologist2015，20，5：	1
9	Immunogenicityof a fucosyl-GM 1 -keyhole limpet hemocyanin conjugatevaccine in patients with small cell lung cancer 显示文摘	Dickler MN Ragupathi G Liu NX	1999	ClinCancer Res1999，5，10：	1
10	A phase Ⅱ trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer显示文摘	Dickler MN Rugo HS Eberle CA	2008	Clin Cancer Res2008，14，23：	1
11	Efficacy and safe-ty of erlotinib in patients with locally advanced or metastaticbreast cancer显示文摘	Dickler MN Cobleigh MA Miller KD	2009	Breast Cancer Res Treat2009，115，11：	1
12	Immunogenicity of a fucosyl-GMl-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer 显示文摘	Dickler MN Ragupathi G Liu NX	1999	Clin Cancer Res1999，5，10：	1
13	Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer 显示文摘	Dickler MN Cobleigh MA Miller KD	2009	Breast Cancer Res Treat2009，115，1：	1
14	A phase Ⅱ trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer 显示文摘	Dickler MN Rugo HS Eberle CA	2008	Clin Cancer Res2008，14，23：	1
15	Alopecia with endocrine therapies in patients with cancer显示文摘	Saggar V Wu S Dickler MN	2013	Oncologist2013，18，10：	1
16	Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer显示文摘	Dickler MN Cobleigh MA Miller KD	2009	Breast Cancer Res Treat2009，115，1：	1
17	A phase II trial of edotin- ib in combination with bevacizumab in patients with metastatic breast cancer 显示文摘	Dickler MN Rugo HS Ebede CA	2008	Clin Cancer Res2008，14，23：	1
18	Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer 显示文摘	Dickler MN Cobleigh MA Miller KD	2009	Breast Cancer Res Treat2009，115，1：	1
19	Maximizing the potential of bevacizumab in cancer treatment 显示文摘	Bergsland E Dickler MN	2004	Oncologist2004，9，1：	1
20	Efficacyand safety of erlotinib in patients with locally advanced ormetastatic breast cancer 显示文摘	Dickler MN Cobleigh MA Miller KD	2009	Breast Cancer Res Treat2009，115，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示